Study of GS-4528 for Adults With Solid Tumors
Researchers are starting a new study to learn about an investigational medicine called GS-4528. This medicine is designed for adults who have solid tumours, which are common types of cancer that form solid growths in the body. Since this is the first time GS-4528 is being given to humans, the main aim is to carefully check its safety and how the human body reacts to it. This kind of early study helps doctors understand if a new medicine might be helpful in the future and what doses might be right. If you have a solid tumour and are an adult, you might be able to take part in this important research. The study will help scientists work towards better treatments for cancer.
At a glance
What is this study about?
This study is called 'Study of GS-4528 for Adults With Solid Tumors', and it's looking into a new medicine known as GS-4528. When scientists are developing new medicines, they go through different stages to make sure they are safe and effective. This particular study is in the very early stages, sometimes called 'Phase 1'. This means it's the first time the medicine GS-4528 is being given to people. The main goals at this stage are to understand if the medicine is safe for humans and how the body handles it – for example, how much of it stays in the body and for how long.
The health problem this study is focusing on is called 'solid tumours'. These are types of cancer that form a solid mass or growth, rather than cancers that affect the blood, like leukaemia. Many different kinds of cancer are solid tumours, such as breast cancer, lung cancer, and bowel cancer. The study is open to adults who have been diagnosed with solid tumours.
Taking part in studies like this is really important because it helps doctors and scientists learn more about new treatments. Even though this is an early study, the information gathered will help decide if GS-4528 could be a promising new medicine for people with solid tumours in the future. It’s a key step in developing new ways to fight cancer.
Key takeaways
- This study is testing a new medicine, GS-4528, for adults with solid tumours.
- It's the first time this medicine is being given to people (Phase 1), focusing on safety and how the body reacts.
- Participation involves receiving the new medicine and regular health checks.
- Both men and women aged 18 and over can be considered.
- You can stop taking part at any time without affecting your usual care.
- The study aims to gather important information for future cancer treatments.
Who may be eligible?
This study is open to adults who have been diagnosed with a solid tumour. A solid tumour is a type of cancer that forms a solid mass or growth, as opposed to blood cancers like leukaemia. If you are 18 years old or older, you could potentially be considered for this study.
Both men and women can take part. Beyond your age and having a solid tumour, there will be other specific health checks and tests to see if the study medicine is suitable for you. These checks are put in place to ensure your safety and that the study results are as clear as possible.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with a solid tumour (a type of cancer that forms a lump or growth)?
- Are you able to attend regular clinic visits for checks and tests?
- Are you comfortable with receiving a new, investigational medicine?
What does participation involve?
If you decide to take part, you would receive the new medicine, GS-4528. As this is an early-stage study (Phase 1), you would likely have regular visits to the clinic. These visits would involve health checks, blood tests, and possibly other scans or tests to see how your body is responding to the medicine and if there are any side effects. The study team would carefully explain the schedule of visits and what each one involves. You would also have follow-up appointments after you stop taking the medicine. The total length of your participation would be fully explained before you join.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What is a 'solid tumour'?
A solid tumour is a type of cancer that forms a lump or growth in the body, such as breast cancer or lung cancer. It's different from blood cancers like leukaemia.
What does 'Phase 1' mean for this study?
Phase 1 means this is the very first time the medicine GS-4528 is being given to people. The main goal is to check its safety and how the body handles it, rather than primarily seeing how well it treats the cancer at this stage.
Will I definitely get the new medicine?
Yes, if you meet all the study requirements and choose to take part, you would receive the new medicine, GS-4528.
How long would I need to be in the study?
The exact duration of your participation, including visits and follow-up, would be explained to you in detail by the study team before you decide to join.
Can I stop participating in the study at any time?
Yes, definitely. You are free to withdraw from the study at any point, for any reason, without it affecting your standard medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.